Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence

<b>Background/Objectives:</b> Lichen planus (LP) is a chronic inflammatory disease of autoimmune origin, affecting the skin and mucous membranes. While corticosteroids and immunosuppressants are traditionally used, many cases remain refractory or intolerant to standard therapies. Recent...

Full description

Bibliographic Details

Published in:	Antibodies
Main Authors:	Francois Rosset, Nadia Sciamarrelli, Luca Mastorino, Valentina Pala, Sara Boskovic, Eleonora Bongiovanni, Orsola Crespi, Yingying Liao, Simone Ribero, Pietro Quaglino
Format:	Article
Language:	English
Published:	MDPI AG 2025-09-01
Subjects:	lichen planus biologic therapy monoclonal antibodies JAK inhibitors targeted immunotherapy IL-17
Online Access:	https://www.mdpi.com/2073-4468/14/3/79